Influence of verapamil on the pharmacokinetics of rotundic acid in rats and its potential mechanism

References

• Aro AO, Dzoyem JP, Awouafack MD, Selepe MA, Eloff JN, McGaw LJ. 2019. Fractions and isolated compounds from Oxyanthus speciosus subsp. stenocarpus (Rubiaceae) have promising antimycobacterial and intracellular activity. BMC Complement Altern Med. 19(1):108.
   PubMedGoogle Scholar
• Cao J, Chen X, Liang J, Yu XQ, Xu AL, Chan E, Wei D, Huang M, Wen JY, Yu XY, et al. 2007. Role of P-glycoprotein in the intestinal absorption of glabridin, an active flavonoid from the root of Glycyrrhiza glabra. Drug Metab Dispos. 35(4):539–553.
   PubMed Web of Science ®Google Scholar
• Chinese Pharmacopoeia Commission. 2015. Pharmacopoeia of the People’s Republic of China. Beijing (China): China Medical Science Press.
   Google Scholar
• Dinger J, Meyer MR, Maurer HH. 2014. Development of an in vitro cytochrome P450 cocktail inhibition assay for assessing the inhibition risk of drugs of abuse. Toxicol Lett. 230(1):28–35.
   PubMed Web of Science ®Google Scholar
• Guo L, Cui Y, Hao KJ. 2018. Effects of glycyrrhizin on the pharmacokinetics of asiatic acid in rats and its potential mechanism. Pharm Biol. 56(1):119–123.
   PubMed Web of Science ®Google Scholar
• Han Y, Zhang L, Li W, Liu X, Xiao J, Chen G, Li N. 2019. Natural CAC chemopreventive agents from Ilex rotunda Thunb. J Nat Med. 73(3):456–467.
   PubMed Web of Science ®Google Scholar
• He YF, Wei ZH, Xie Y, Yi XL, Zeng Y, Li YZ, Liu CX. 2020. Potential synergic mechanism of Wutou-Gancao herb-pair by inhibiting efflux transporter P-glycoprotein. J Pharm Anal. 10(2):178–186.
   PubMed Web of Science ®Google Scholar
• Hsu YM, Hung YC, Hu L, Lee YJ, Yin MC. 2015. Anti-diabetic effects of madecassic acid and rotundic acid. Nutrients. 7(12):10065–10075.
   PubMed Web of Science ®Google Scholar
• Jeong DW, Kim YH, Kim HH, Ji HY, Yoo SD, Choi WR, Lee SM, Han CK, Lee HS. 2007. Dose-linear pharmacokinetics of oleanolic acid after intravenous and oral administration in rats. Biopharm Drug Dispos. 28(2):51–57.
   PubMed Web of Science ®Google Scholar
• Lee CK, Ki SH, Choi JS. 2011. Effects of oral curcumin on the pharmacokinetics of intravenous and oral etoposide in rats: possible role of intestinal CYP3A and P-gp inhibition by curcumin. Biopharm Drug Dispos. 32(4):245–251.
   PubMed Web of Science ®Google Scholar
• Lee KS, Kim SK. 2013. Direct and metabolism-dependent cytochrome P450 inhibition assays for evaluating drug-drug interactions. J Appl Toxicol. 33(2):100–108.
   PubMed Web of Science ®Google Scholar
• Li H, Liu L, Xie L, Gan DM, Jiang XQ. 2016. Effects of berberine on the pharmacokinetics of losartan and its metabolite EXP3174 in rats and its mechanism. Pharm Biol. 54(12):2886–2894.
   PubMed Web of Science ®Google Scholar
• Liu HC, Yin W. 2016. Reducing dental plaque and gingivitis with 0.6% Cortex Ilicis Rotundae toothpaste: a randomized, double-masked clinical trial. J Periodontol. 87(3):327–333.
   PubMed Web of Science ®Google Scholar
• Liu L, Li PH, Qiao LJ, Li XH. 2019. Effects of astragaloside IV on the pharmacokinetics of puerarin in rats. Xenobiotica. 49(10):1173–1177.
   PubMed Web of Science ®Google Scholar
• Ma B, Prueksaritanont T, Lin JH. 2000. Drug interactions with calcium channel blockers: possible involvement of metabolite-intermediate complexation with CYP3A. Drug Metab Dispos. 28(2):125–130.
   PubMed Web of Science ®Google Scholar
• Mahringer A, Karamustafa S, Klotz D, Kahl S, Konkimalla VB, Wang YF, Wang JS, Liu HY, Boechzelt H, Hao XJ, et al. 2010. Inhibition of P-glycoprotein at the blood-brain barrier by phytochemicals derived from traditional Chinese medicine. Cancer Genom Proteom. 7:191–206.
   PubMedGoogle Scholar
• Nan ML, He YF, Zhao YW, Lü N, Si XL, Li K, He ZM. 2016. Oral bioavailability study of rotundic acid in rats. China Pharm. 19:1648–1650.
   Google Scholar
• Nguyen HT, Ho DV, Vo HQ, Le AT, Nguyen HM, Kodama T, Ito T, Morita H, Raal A. 2017. Antibacterial activities of chemical constituents from the aerial parts of Hedyotis pilulifera. Pharm Biol. 55(1):787–791.
   PubMed Web of Science ®Google Scholar
• Peterson B, Weyers M, Steenekamp JH, Steyn JD, Gouws C, Hamman JH. 2019. Drug bioavailability enhancing agents of natural origin (Bioenhancers) that modulate drug membrane permeation and pre-systemic metabolism. Pharmaceutics. 11(1):33.
   PubMed Web of Science ®Google Scholar
• Rautio J, Humphreys JE, Webster LO, Balakrishnan A, Keogh JP, Kunta JR, Serabjit-Singh CJ, Polli JW. 2006. In vitro P-glycoprotein inhibition assays for assessment of clinical drug interaction potential of new drug candidates: a recommendation for probe substrates. Drug Metab Dispos. 34(5):786–792.
   PubMed Web of Science ®Google Scholar
• Roy G, Guan S, Liu HX, Zhang L. 2019. Rotundic acid induces DNA damage and cell death in hepatocellular carcinoma through AKT/mTOR and MAPK pathways. Front Oncol. 9:545.
   PubMedGoogle Scholar
• Saimaru H, Orihara Y, Tansakul P, Kang YH, Shibuya M, Ebizuka Y. 2007. Production of triterpene acids by cell suspension cultures of Olea europaea. Chem Pharm Bull. 55(5):784–788.
   PubMed Web of Science ®Google Scholar
• Shi XB, Zhang G, Mackie B, Yang SM, Wang J, Shan LN. 2016. Comparison of the in vitro metabolism of psoralidin among different species and characterization of its inhibitory effect against UDP- glucuronosyltransferase (UGT) or cytochrome p450 (CYP450) enzymes. J Chromatogr B Analyt Technol Biomed Life Sci. 1029–1030:145–156.
   PubMed Web of Science ®Google Scholar
• Srinivas NR. 2008. Dual drug interactions via P-glycoprotein (P-gp)/ cytochrome P450 (CYP3A4) interplay: recent case study of oral atorvastatin and verapamil. Eur J Clin Pharmacol. 64(11):1135–1136.
   PubMed Web of Science ®Google Scholar
• Sun HJ, Wang JF, Lv J. 2019. Effects of glycyrrhizin on the pharmacokinetics of paeoniflorin in rats and its potential mechanism. Pharm Biol. 57(1):550–554.
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration. 2005. Guidance for industry-estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers. Silver Spring (MD): US Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research (CDER).
   Google Scholar
• Wang XM, Zhang X, Huang XH, Li YT, Wu MC, Liu JF. 2016. The drug-drug interaction of sorafenib mediated by P-glycoprotein and CYP3A4. Xenobiotica. 46(7):651–658.
   PubMed Web of Science ®Google Scholar
• Wang Z, Kurosaki Y, Nakayama T, Kimura T. 1994. Mechanism of gastrointestinal absorption of glycyrrhizin in rats. Biol Pharm Bull. 17(10):1399–1403.
   PubMed Web of Science ®Google Scholar
• Wang ZF, Sun WY, Yu DH, Zhao Y, Xu HM, He YF, Li HJ. 2018. Rotundic acid enhances the impact of radiological toxicity on MCF-7 cells through the ATM/p53 pathway. Int J Oncol. 53(5):2269–2277.
   PubMed Web of Science ®Google Scholar
• Xiang QF, Zhang WJ, Li Q, Zhao J, Feng WW, Zhao T, Mao GH, Chen Y, Wu XY, Yang LQ, et al. 2020. Investigation of the uptake and transport of polysaccharide from Se-enriched Grifola. frondosa in Caco-2 cells model. Int J Biol Macromol. 158:1330–1341.
   Web of Science ®Google Scholar
• Xing H, Luo X, Li Y, Fan CN, Liu N, Cui CG, Li WJ. 2020. Effect of verapamil on the pharmacokinetics of hydroxycamptothecin and its potential mechanism. Pharm Biol. 58(1):152–156.
   PubMed Web of Science ®Google Scholar
• Yan GK, Zhang HH, Wang W, Li Y, Mao CH, Fang MQ, Yi XH, Zhang JD. 2017. Investigation of the influence of glycyrrhizin on the pharmacokinetics of celastrol in rats using LC-MS and its potential mechanism. Xenobiotica. 47(7):607–613.
   PubMed Web of Science ®Google Scholar
• Yan ZH, Wu H, Yao HL, Pan WJ, Su MM, Chen TB, Su WW, Wang YG. 2019. Rotundic acid protects against metabolic disturbance and improves gut microbiota in Type 2 diabetes rats. Nutrients. 12(1):67.
   PubMed Web of Science ®Google Scholar
• Yang B, Li H, Ruan QF, Tong Y, Liu ZQ, Xuan SX, Jin J, Zhao ZX. 2018. Rapid profiling and pharmacokinetic studies of multiple potential bioactive triterpenoids in rat plasma using UPLC/Q-TOF-MS/MS after oral administration of Ilicis Rotundae Cortex extract. Fitoterapia. 129:210–219.
   PubMed Web of Science ®Google Scholar
• Yang B, Li H, Ruan QF, Xue YY, Cao D, Zhou XH, Jiang SQ, Yi T, Jin J, Zhao ZX. 2018. A facile and selective approach to the qualitative and quantitative analysis of triterpenoids and phenylpropanoids by UPLC/Q-TOF-MS/MS for the quality control of Ilex rotunda. J Pharm Biomed Anal. 157:44–58.
   PubMed Web of Science ®Google Scholar
• Yang B, Xuan SX, Ruan QF, Jiang SQ, Cui H, Zhu LP, Luo X, Jin J, Zhao ZX. 2020. UPLC/Q-TOF-MS/MS-based metabolomics revealed the lipid-lowering effect of Ilicis Rotundae Cortex on high-fat diet induced hyperlipidemia rats. J Ethnopharmacol. 256:112784.
   PubMed Web of Science ®Google Scholar
• Yang MF, Cheng XH, Xu WW. 2017. Absorption characteristics and mechanism of P-glycoprotein mediated transport of oleanolic acidin across the membrane in vitro. Her Med. 36:247–251.
   Google Scholar
• Zhang YZ, Wu JJ, Zhou Y, Yin YL, Chen HF. 2018. Effects of psoralen on the pharmacokinetics of anastrozole in rats. Pharm Biol. 56(1):433–439.
   PubMed Web of Science ®Google Scholar
• Zhao K, Ding M, Cao H, Cao ZX. 2012. In-vitro metabolism of glycyrrhetinic acid by human and rat liver microsomes and its interactions with six CYP substrates. J Pharm Pharmacol. 64(10):1445–1451.
   PubMed Web of Science ®Google Scholar
• Zhao QL, Wei JL, Zhang HY. 2019. Effects of quercetin on the pharmacokinetics of losartan and its metabolite EXP3174 in rats. Xenobiotica. 49(5):563–568.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Song XL, Dong G. 2019. Effects of verapamil on the pharmacokinetics of puerarin in rats. Xenobiotica. 49(10):1178–1182.
   PubMed Web of Science ®Google Scholar
• Zhu JP, Yang B, Yang T, Tan QL, Tong JY, Tong PZ, Rong L, Zhao ZX. 2015. Simultaneous determination of four constituents in Cortex Ilicis Rotundae with HPLC. Tradit Chin Drug Res Pharmacol. 26:558–560.
   Google Scholar
• Zhu T, Howieson C, Wojtkowski T, Garg JP, Han D, Fisniku O, Keirns J. 2017. The effect of verapamil, a P-glycoprotein inhibitor, on the pharmacokinetics of peficitinib, an orally administered, once-daily JAK inhibitor. Clin Pharmacol Drug Dev. 6(6):548–555.
   PubMed Web of Science ®Google Scholar